Cargando…
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system characterized by broad inter- and intraindividual heterogeneity. The relapse rate, disability progression, and lesion load assessed through MRI are used to detect disease activity and response to t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024668/ https://www.ncbi.nlm.nih.gov/pubmed/35455665 http://dx.doi.org/10.3390/jpm12040549 |